No headlines found.
USANA Celavive Postbiotic Barrier Balm Named to Best in Skincare List
PRNewswire (Thu, 23-May 2:44 PM ET)
USANA HR Executive Awarded for Excellence in his Field
PRNewswire (Wed, 15-May 8:08 AM ET)
USANA Executive Chairman Kevin Guest Advocates for Family Wellness in May's Celebratory Month
PRNewswire (Fri, 3-May 7:17 AM ET)
USANA Health Sciences Reports First Quarter 2024 Results
Business Wire (Tue, 30-Apr 4:05 PM ET)
USANA Releases 2023 Sustainability Report
PRNewswire (Mon, 29-Apr 7:47 AM ET)
USANA Honored with Local Healthy Worksite Award
PRNewswire (Thu, 25-Apr 10:45 AM ET)
USANA Schedules First Quarter 2024 Earnings Release and Conference Call
Business Wire (Wed, 10-Apr 4:15 PM ET)
USANA Cements Itself as a Premier Cellular Nutrition Company in South Korea
PRNewswire (Tue, 9-Apr 9:08 AM ET)
PRNewswire (Tue, 2-Apr 7:17 AM ET)
Kevin Guest Says Leap Forward on Leap Day
PRNewswire (Wed, 28-Feb 7:03 AM ET)
Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling. It owns a number of product lines, such as Essentials, which contains core vitamin and mineral supplements; Optimizers, which includes targeted supplements for individuals' health and nutritional needs; Foods, which consists of low-glycemic meal replacement shakes, snack bars, and other related products; and Sense Beautiful Science, which contains personal-care products related to skin and hair. The company conducts business worldwide, including Asia-Pacific, the Americas, and Europe.
Usana Health Sciences trades on the NYSE stock market under the symbol USNA.
As of May 24, 2024, USNA stock price declined to $46.71 with 42,178 million shares trading.
USNA has a beta of 0.95, meaning it tends to be less sensitive to market movements. USNA has a correlation of 0.13 to the broad based SPY ETF.
USNA has a market cap of $889.85 million. This is considered a Small Cap stock.
Last quarter Usana Health Sciences reported $228 million in Revenue and $.86 earnings per share. This beat revenue expectation by $880,000 and exceeded earnings estimates by $.17.
In the last 3 years, USNA stock traded as high as $107.85 and as low as $41.45.
The top ETF exchange traded funds that USNA belongs to (by Net Assets): IJR, CALF, VTI, IWM, VB.
USNA has underperformed the market in the last year with a price return of -25.5% while the SPY ETF gained +29.5%. USNA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -4.2% and +0.8%, respectively, while the SPY returned +4.6% and +1.8%, respectively.
USNA support price is $46.92 and resistance is $48.72 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that USNA stock will trade within this expected range on the day.